Ningbo MedicalSystem (China) Technical Analysis
| 300439 Stock | 11.61 0.11 0.96% |
As of the 2nd of December, Ningbo MedicalSystem secures the Risk Adjusted Performance of 0.1086, coefficient of variation of 757.4, and Semi Deviation of 2.45. Ningbo MedicalSystem Biotechnology technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.
Ningbo MedicalSystem Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Ningbo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NingboNingbo |
Ningbo MedicalSystem technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Ningbo MedicalSystem Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Ningbo MedicalSystem volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Ningbo MedicalSystem Trend Analysis
Use this graph to draw trend lines for Ningbo MedicalSystem Biotechnology. You can use it to identify possible trend reversals for Ningbo MedicalSystem as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Ningbo MedicalSystem price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Ningbo MedicalSystem Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Ningbo MedicalSystem Biotechnology applied against its price change over selected period. The best fit line has a slop of 0.05 , which means Ningbo MedicalSystem Biotechnology will continue generating value for investors. It has 122 observation points and a regression sum of squares at 79.01, which is the sum of squared deviations for the predicted Ningbo MedicalSystem price change compared to its average price change.About Ningbo MedicalSystem Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Ningbo MedicalSystem Biotechnology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Ningbo MedicalSystem Biotechnology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Ningbo MedicalSystem price pattern first instead of the macroeconomic environment surrounding Ningbo MedicalSystem. By analyzing Ningbo MedicalSystem's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Ningbo MedicalSystem's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Ningbo MedicalSystem specific price patterns or momentum indicators. Please read more on our technical analysis page.
Ningbo MedicalSystem December 2, 2024 Technical Indicators
Most technical analysis of Ningbo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ningbo from various momentum indicators to cycle indicators. When you analyze Ningbo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1086 | |||
| Mean Deviation | 2.08 | |||
| Semi Deviation | 2.45 | |||
| Downside Deviation | 2.82 | |||
| Coefficient Of Variation | 757.4 | |||
| Standard Deviation | 3.32 | |||
| Variance | 11.0 | |||
| Information Ratio | 0.0905 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.1064 | |||
| Maximum Drawdown | 23.23 | |||
| Value At Risk | (3.34) | |||
| Potential Upside | 4.72 | |||
| Downside Variance | 7.98 | |||
| Semi Variance | 5.99 | |||
| Expected Short fall | (2.50) | |||
| Skewness | 0.9246 | |||
| Kurtosis | 5.67 |
Complementary Tools for Ningbo Stock analysis
When running Ningbo MedicalSystem's price analysis, check to measure Ningbo MedicalSystem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ningbo MedicalSystem is operating at the current time. Most of Ningbo MedicalSystem's value examination focuses on studying past and present price action to predict the probability of Ningbo MedicalSystem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ningbo MedicalSystem's price. Additionally, you may evaluate how the addition of Ningbo MedicalSystem to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |